Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1038 | 930 | 1088 | 1009 | 1298 | 1526 |
Fund Return | 3.84% | -6.99% | 8.84% | 0.29% | 5.35% | 4.31% |
Place in category | 62 | 53 | 67 | 59 | 57 | 38 |
% in Category | 68 | 60 | 74 | 72 | 71 | 82 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 35.09B | 15.10 | 7.45 | 10.77 | ||
T. Rowe Price Blue Chip Growth | 32.6B | 36.09 | 7.62 | 14.78 | ||
T. Rowe Price Blue Chip Growth I | 29.84B | 36.24 | 7.76 | - | ||
T. Rowe Price Capital AppreciationI | 28.77B | 15.25 | 7.60 | - | ||
T. Rowe Price Instl Large Cap Growt | 22.6B | 32.75 | 8.37 | 16.17 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard European Stock Index Adm | 4.77B | 4.71 | 3.74 | 5.05 | ||
Fidelity Europe | 524.45M | 6.35 | 0.10 | 4.41 | ||
Vanguard European Stock Index I | 827.85M | 4.73 | 3.76 | 5.07 | ||
DFA Continental Small Company I | 110.83M | 1.82 | -0.15 | 7.25 | ||
Brown Advisory WMC Strat Eurp Eq In | 320.98M | 13.22 | 8.34 | 7.80 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.94 | 602.8 | -2.51% | |
ASML Holding | NL0010273215 | 3.74 | 738.40 | -1.26% | |
SAP | DE0007164600 | 3.64 | 243.300 | +1.69% | |
AstraZeneca | GB0009895292 | 3.34 | 10,668.0 | -0.41% | |
Unilever | GB00B10RZP78 | 2.85 | 54.16 | +1.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Sell |
Technical Indicators | Sell | Strong Sell | Sell |
Summary | Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review